本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enliven Treateutics

50.24
+1.122.28%
盤後50.710.4700+0.94%17:35 EDT
成交量:196.35萬
成交額:9,902.40萬
市值:36.81億
市盈率:-29.99
高:51.83
開:49.58
低:49.32
收:49.12
52周最高:62.32
52周最低:14.79
股本:7,327.08萬
流通股本:6,172.59萬
量比:1.53
換手率:3.18%
股息:- -
股息率:- -
每股收益(TTM):-1.6753
每股收益(LYR):-1.8300
淨資產收益率:-15.31%
總資產收益率:-11.00%
市淨率:4.11
市盈率(LYR):-27.45

資料載入中...

2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/04/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/04

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/03

重要事件披露

Form 8-K - Current report
2026/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities